FDA WARNING_LETTER - US Stem Cell Clinic, LLC - May 11, 2017

FDA WARNING_LETTER for US Stem Cell Clinic, LLC on May 11, 2017. Product: Biologics. Access full analysis and detailed observations.

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA WARNING_LETTER for US Stem Cell Clinic, LLC on May 11, 2017. Product: Biologics. Access full analysis and detailed observations.

Violation Codes

21 CFR 312

21 CFR 1271.10(a)

21 CFR 1271.3(f)(1)

42 U.S.C. 264

21.U.S.C. 355(a)

21 CFR 210

21 CFR 211

21 U.S.C. 351(a)(2)(B)

21 CFR 211.182

21 U.S.C. 374

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

US Stem Cell Clinic, LLC

Inspection Date

May 11, 2017

Product Type

Biologics

Office

Florida District Office

People

ID: 22bea09c-22d6-4c25-8706-fe26cd4c4393

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox